Net Cash Provided by (Used in) Financing Activities of BIOVIE INC. from 31 Mar 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BIOVIE INC. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2014 to 30 Sep 2025.
  • BIOVIE INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Sep 2025 was $10,457,629.
  • BIOVIE INC. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $12,725,954, a 29% decline from 2024.
  • BIOVIE INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $17,802,939, a 68% decline from 2023.
  • BIOVIE INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $55,373,183, a 67% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

BIOVIE INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $10,457,629 +$10,698,566 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2026 Q1
Q3 2024 $240,937 +$353,227 +59% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2026 Q1
Q3 2023 $594,164 -$12,403,686 -105% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q1
Q3 2022 $11,809,522 -$6,701,487 -36% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q1
Q3 2021 $18,511,009 +$4,268,817 +30% 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022 2022 Q1
Q3 2020 $14,242,192 +$13,742,192 +2748% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2022 Q1
Q3 2019 $500,000 -$2,031,700 -80% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2021 Q1
Q3 2018 $2,531,700 +$2,311,699 +1051% 01 Jul 2018 30 Sep 2018 10-Q 19 Nov 2019 2020 Q1
Q3 2017 $220,001 +$207,001 +1592% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2019 Q1
Q3 2016 $13,000 +$13,000 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017 2017 Q1
Q3 2015 $0 01 Jul 2015 30 Sep 2015 10-Q/A 19 Jan 2017 2016 Q1

BIOVIE INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $12,725,954 -$5,076,985 -29% 01 Jul 2024 30 Jun 2025 10-K 15 Aug 2025 2025 FY
2024 $17,802,939 -$37,570,244 -68% 01 Jul 2023 30 Jun 2024 10-K 15 Aug 2025 2025 FY
2023 $55,373,183 +$22,252,259 +67% 01 Jul 2022 30 Jun 2023 10-K 30 Sep 2024 2024 FY
2022 $33,120,924 +$18,193,430 +122% 01 Jul 2021 30 Jun 2022 10-K 16 Aug 2023 2023 FY
2021 $14,927,494 +$13,601,994 +1026% 01 Jul 2020 30 Jun 2021 10-K 27 Sep 2022 2022 FY
2020 $1,325,500 -$1,470,200 -53% 01 Jul 2019 30 Jun 2020 10-K 30 Aug 2021 2021 FY
2019 $2,795,700 +$2,133,701 +322% 01 Jul 2018 30 Jun 2019 10-K/A 07 Aug 2020 2020 FY
2018 $661,999 +$157,000 +31% 01 Jul 2017 30 Jun 2018 10-K 27 Sep 2019 2018 FY
2017 $504,999 +$505,004 01 Jul 2016 30 Jun 2017 10-K 05 Oct 2018 2018 FY
2016 $5* 01 Jul 2015 30 Jun 2016 10-K 24 Aug 2017 2017 FY
2013 $508,206 10 Apr 2013 31 Mar 2014 10-Q 09 May 2014 2014 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.